Patents by Inventor Mark Q. Niederauer
Mark Q. Niederauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220193326Abstract: A wound treatment system includes a processor coupled to sensor system(s), a power delivery system, an oxygen concentrator coupled to the power delivery system and including an oxygen outlet coupled to a restricted airflow enclosure provided by a dressing and located adjacent a wound site, and a negative pressure system that includes a negative pressure outlet coupled to the restricted airflow enclosure. The processor receives first sensor information from the sensor system(s), and uses the first sensor information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through the oxygen outlet to the restricted airflow enclosure. When the processor receives second sensor information from the sensor system(s), it activates the negative pressure system to create a fluid flow from the restricted airflow enclosure and through the negative pressure outlet.Type: ApplicationFiled: April 15, 2020Publication date: June 23, 2022Applicant: ELECTROCHEMICAL OXYGEN CONCEPTS, INC.Inventors: Mark Q. NIEDERAUER, James P. DALEY, Joseph J. MOFFETT
-
Patent number: 10702686Abstract: A wound oxygen supply system includes a chassis that defines an oxygen outlet. an oxygen production subsystem is included in the chassis and coupled to the oxygen outlet. A control subsystem is coupled to the oxygen production subsystem and configured to receive humidity information that is indicative of a humidity experienced by the oxygen production subsystem. The control system then uses the humidity information to control power provided to the oxygen production subsystem in order to control an oxygen flow that is created by the oxygen production subsystem and provided through the oxygen outlet to a restricted airflow enclosure adjacent a wound site.Type: GrantFiled: June 30, 2017Date of Patent: July 7, 2020Assignee: Electrochemical Oxygen Concepts, Inc.Inventors: Mark Q. Niederauer, James P. Daley, Joseph J. Moffett
-
Patent number: 10632018Abstract: A wound treatment system includes a housing that defines an oxygen outlet. An oxygen production subsystem is included in the housing and coupled to the oxygen outlet. A control subsystem is coupled to the oxygen production subsystem and configured to receive pressure information that is indicative of a pressure in a restricted airflow enclosure that is coupled to the oxygen outlet. The control subsystem then uses the pressure information to control power provided to the oxygen production subsystem in order to control an oxygen flow that is created by the oxygen production subsystem and provided through the oxygen outlet to the restricted airflow enclosure.Type: GrantFiled: July 6, 2017Date of Patent: April 28, 2020Assignee: ELECTROCHEMICAL OXYGEN CONCEPTS, INC.Inventors: Michael C. Wells, Mark Parker, Daniel J. Clarius, Andrew Parker, Faraidoon Pundole, Tom Woods, Mark Q. Niederauer, James P. Daley
-
Publication number: 20190001107Abstract: A wound oxygen supply system includes a chassis that defines an oxygen outlet. an oxygen production subsystem is included in the chassis and coupled to the oxygen outlet. A control subsystem is coupled to the oxygen production subsystem and configured to receive humidity information that is indicative of a humidity experienced by the oxygen production subsystem. The control system then uses the humidity information to control power provided to the oxygen production subsystem in order to control an oxygen flow that is created by the oxygen production subsystem and provided through the oxygen outlet to a restricted airflow enclosure adjacent a wound site.Type: ApplicationFiled: June 30, 2017Publication date: January 3, 2019Applicant: Electrochemical Oxygen Concepts, Inc.Inventors: Mark Q. Niederauer, James P. Daley, Joseph J. Moffett
-
Patent number: 10105265Abstract: Examples include devices, systems and methods related to advanced wound therapy dressings. Specific examples are optimized for use with mobile continuous diffusion of oxygen therapy systems for the localized delivery of oxygen to damaged and healing tissues. Examples may utilize a conduit to deliver therapeutic fluids, including for example oxygen, where the conduit comprises a plurality of apertures or perforations. Examples may also include a spacer material with a plurality of distribution channels in fluid communication with the conduit.Type: GrantFiled: February 11, 2014Date of Patent: October 23, 2018Assignee: ELECTROCHEMICAL OXYGEN CONCEPTS, INC.Inventors: Mark Q. Niederauer, James P. Daley, Alan S. Neil
-
Publication number: 20170296392Abstract: A wound treatment system includes a housing that defines an oxygen outlet. An oxygen production subsystem is included in the housing and coupled to the oxygen outlet. A control subsystem is coupled to the oxygen production subsystem and configured to receive pressure information that is indicative of a pressure in a restricted airflow enclosure that is coupled to the oxygen outlet. The control subsystem then uses the pressure information to control power provided to the oxygen production subsystem in order to control an oxygen flow that is created by the oxygen production subsystem and provided through the oxygen outlet to the restricted airflow enclosure.Type: ApplicationFiled: July 6, 2017Publication date: October 19, 2017Applicant: ELECTROCHEMICAL OXYGEN CONCEPTS, INC.Inventors: Michael C. Wells, Mark Parker, Daniel J. Clarius, Andrew Parker, Faraidoon Pundole, Tom Woods, Mark Q. Niederauer, James P. Daley
-
Publication number: 20160000611Abstract: Embodiments of the present disclosure comprise devices, systems and methods related to advanced wound therapy dressings. Specific embodiments are optimized for use with mobile continuous diffusion of oxygen therapy systems for the localized delivery of oxygen to damaged and healing tissues. Exemplary embodiments may utilize a conduit to deliver therapeutic fluids, including for example oxygen, whereby the conduit comprises a plurality of apertures or perforations. Exemplary embodiments may also comprise a spacer material with a plurality of distribution channels in fluid communication with the conduit.Type: ApplicationFiled: February 11, 2014Publication date: January 7, 2016Inventors: Mark Q. NIEDERAUER, James P. DALEY, Alan S. NEIL
-
Publication number: 20140276196Abstract: An allergy testing device is formed by a blister pack containing a series of collapsible chambers each associated with an allergen and a lancet. The allergy testing device may be placed adjacent to a patient's skin and actuated by applying pressure to the collapsible chambers to open the chambers and release the reagents contained therein. The lancets deliver the allergen to the skin. The allergy testing device may apply marking to the skin to allow accurate measurement of the allergy testing results.Type: ApplicationFiled: March 13, 2014Publication date: September 18, 2014Applicant: ALLERGY DEVICES, INC.Inventors: Mark Q. Niederauer, Patrick Strauss
-
Publication number: 20040193154Abstract: A method and device for inserting an implant of synthetic material or healthy bone or cartilage into a bone or cartilage defect of unknown depth. The device includes an inner shaft within a hollow outer shaft. One end of the inner shaft of the device is suitable for inserting into the bone or cartilage defect in order to determine the depth, while the other end of the outer shaft is suitable for holding an implant. The implant is cut to fit the defect once its depth has been determined and then inserted into the defect. A cutting device for cutting the implant is disclosed. Also disclosed is an implant capsule loader for inserting an implant into the delivery device.Type: ApplicationFiled: February 23, 2004Publication date: September 30, 2004Applicant: OsteoBiologics, Inc.Inventors: Neil C. Leatherbury, Mark Q. Niederauer, Fred B. Dinger, Joe D. Blandford
-
Publication number: 20010051833Abstract: This invention provides molded, biodegradable porous polymeric implant materials having a pore size distribution throughout the material which is substantially uniform. These materials can be molded into implants of any desired size and shape without loss of uniformity of pore size distribution. The implants are useful as biodegradable scaffolds for cell growth in healing of tissue defects. Particulate implant materials are provided, especially useful as autologous bone graft materials.Type: ApplicationFiled: March 19, 2001Publication date: December 13, 2001Inventors: Mary Ann Walter, Neil C. Leatherbury, Mark Q. Niederauer
-
Patent number: 6203573Abstract: This invention provides molded, biodegradable porous polymeric implant materials having a pore size distribution throughout the material which is substantially uniform. These materials can be molded into implants of any desired size and shape without loss of uniformity of pore size distribution. The implants are useful as biodegradable scaffolds for cell growth in healing of tissue defects. When manufactured to have an aspect ratio greater than about 3, the implants can be further hand-shaped to fit the defect into which they are placed and the desired shape for the regrown tissue.Type: GrantFiled: January 21, 1999Date of Patent: March 20, 2001Assignee: OsteoBiologics, Inc.Inventors: Mary Ann Walter, Neil C. Leatherbury, Mark Q. Niederauer
-
Patent number: 6156068Abstract: This invention provides molded, biodegradable porous polymeric implant materials having a pore size distribution throughout the material which is substantially uniform. These materials can be molded into implants of any desired size and shape without loss of uniformity of pore size distribution. The implants are useful as biodegradable scaffolds for cell growth in healing of tissue defects. When manufactured to have an aspect ratio greater than about 3, the implants can be further hand-shaped to fit the defect into which they are placed and the desired shape for the regrown tissue.Type: GrantFiled: January 21, 1999Date of Patent: December 5, 2000Assignee: OsteoBiologics, Inc.Inventors: Mary Ann Walter, Neil C. Leatherbury, Mark Q. Niederauer
-
Patent number: 5904658Abstract: A handheld materials testing device is provided for measuring compressive properties of a material, preferably articular cartilage in vivo. The device is computer-controlled and provides a readout indicative of the desired compressive property, which in the case of bodily tissue, may be indicative of the state of health of the tissue. The device does not require precise perpendicular alignment and is preferably capable of compensating for force applied by the user against the tissue.Type: GrantFiled: August 22, 1997Date of Patent: May 18, 1999Assignee: OsteoBiologics, Inc.Inventors: Mark Q. Niederauer, Robert P. Wilkes, George M. Niederauer, Sabine Cristante, Steven F. Cline, Robert A. Tynmann
-
Patent number: 5863297Abstract: This invention provides molded, biodegradable porous polymeric implant materials having a pore size distribution throughout the material which is substantially uniform. These materials can be molded into implants of any desired size and shape without loss of uniformity of pore size distribution. The implants are useful as biodegradable scaffolds for cell growth in healing of tissue defects. When manufactured to have an aspect ratio greater than about 3, the implants can be further hand-shaped to fit the defect into which they are placed and the desired shape for the regrown tissue.Type: GrantFiled: October 8, 1996Date of Patent: January 26, 1999Assignee: OsteoBiologics, Inc.Inventors: Mary Ann Walter, Neil C. Leatherbury, Mark Q. Niederauer
-
Patent number: 5716413Abstract: This invention provides molded, biodegradable porous polymeric implant materials having a pore size distribution throughout the material which is substantially uniform. These materials can be molded into implants of any desired size and shape without loss of uniformity of pore size distribution. The implants are useful as biodegradable scaffolds for cell growth in healing of tissue defects. When manufactured to have an aspect ratio greater than about 3, the implants can be further hand-shaped to fit the defect into which they are placed and the desired shape for the regrown tissue.Type: GrantFiled: October 11, 1995Date of Patent: February 10, 1998Assignee: OsteoBiologics, Inc.Inventors: Mary Ann Walter, Neil C. Leatherbury, Mark Q. Niederauer